PRTA logo

Prothena (PRTA) Free Cash Flow

Annual FCF

-$136.72 M
-$27.43 M-25.10%

December 31, 2023


Summary


Performance

PRTA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTAcash flowmetrics:

Quarterly FCF

-$45.20 M
-$61.01 M-385.75%

September 30, 2024


Summary


Performance

PRTA Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTAcash flowmetrics:

TTM FCF

-$155.12 M
-$54.27 M-53.81%

September 30, 2024


Summary


Performance

PRTA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRTAcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PRTA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.1%+14.1%-13.5%
3 y3 years-69.7%-140.4%-262.1%
5 y5 years-355.1%-391.7%-189.8%

PRTA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-248.6%at low-385.8%+38.2%-268.6%+4.5%
5 y5-year-248.6%at low-140.4%+38.2%-262.1%+4.5%
alltimeall time-248.6%at low-140.4%+38.2%-262.1%+4.5%

Prothena Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$45.20 M(-385.8%)
-$155.12 M(+53.8%)
Jun 2024
-
$15.82 M(-121.6%)
-$100.85 M(-37.9%)
Mar 2024
-
-$73.15 M(+39.1%)
-$162.36 M(+18.8%)
Dec 2023
-$136.72 M(+25.1%)
-$52.59 M(-679.5%)
-$136.72 M(+53.2%)
Sep 2023
-
$9.07 M(-119.9%)
-$89.26 M(-31.1%)
Jun 2023
-
-$45.70 M(-3.8%)
-$129.63 M(+8.6%)
Mar 2023
-
-$47.51 M(+826.6%)
-$119.35 M(+9.2%)
Dec 2022
-$109.28 M(-218.7%)
-$5.13 M(-83.6%)
-$109.28 M(-13.9%)
Sep 2022
-
-$31.30 M(-11.7%)
-$126.94 M(-880.5%)
Jun 2022
-
-$35.42 M(-5.4%)
$16.26 M(-81.6%)
Mar 2022
-
-$37.44 M(+64.4%)
$88.31 M(-4.0%)
Dec 2021
$92.03 M(-214.2%)
-$22.78 M(-120.4%)
$92.03 M(-3.8%)
Sep 2021
-
$111.90 M(+205.6%)
$95.66 M(-367.8%)
Jun 2021
-
$36.62 M(-208.6%)
-$35.72 M(-60.8%)
Mar 2021
-
-$33.71 M(+76.1%)
-$91.08 M(+13.1%)
Dec 2020
-$80.56 M(+50.5%)
-$19.14 M(-1.7%)
-$80.56 M(+6.0%)
Sep 2020
-
-$19.48 M(+3.9%)
-$76.01 M(+15.7%)
Jun 2020
-
-$18.74 M(-19.2%)
-$65.72 M(+11.1%)
Mar 2020
-
-$23.19 M(+58.9%)
-$59.15 M(+10.5%)
Dec 2019
-$53.52 M(+78.2%)
-$14.59 M(+58.8%)
-$53.52 M(-13.0%)
Sep 2019
-
-$9.19 M(-24.5%)
-$61.52 M(-28.5%)
Jun 2019
-
-$12.17 M(-30.7%)
-$86.05 M(+443.1%)
Mar 2019
-
-$17.57 M(-22.2%)
-$15.85 M(-47.3%)
Dec 2018
-$30.04 M
-$22.59 M(-33.0%)
-$30.04 M(-36.6%)
Sep 2018
-
-$33.73 M(-158.1%)
-$47.36 M(+48.4%)
Jun 2018
-
$58.03 M(-282.7%)
-$31.91 M(-74.7%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$31.77 M(-20.4%)
-$126.23 M(-6.4%)
Dec 2017
-$134.81 M(+1.4%)
-$39.90 M(+118.3%)
-$134.81 M(-0.8%)
Sep 2017
-
-$18.28 M(-49.6%)
-$135.86 M(-13.0%)
Jun 2017
-
-$36.29 M(-10.0%)
-$156.20 M(+5.6%)
Mar 2017
-
-$40.34 M(-1.5%)
-$147.94 M(+11.3%)
Dec 2016
-$132.89 M(+121.6%)
-$40.95 M(+6.1%)
-$132.89 M(+22.2%)
Sep 2016
-
-$38.62 M(+37.8%)
-$108.75 M(+24.5%)
Jun 2016
-
-$28.03 M(+10.8%)
-$87.38 M(+23.9%)
Mar 2016
-
-$25.30 M(+50.5%)
-$70.53 M(+17.6%)
Dec 2015
-$59.98 M(+4861.3%)
-$16.81 M(-2.5%)
-$59.98 M(+7.6%)
Sep 2015
-
-$17.24 M(+54.2%)
-$55.76 M(+9.6%)
Jun 2015
-
-$11.18 M(-24.2%)
-$50.89 M(+50.4%)
Mar 2015
-
-$14.75 M(+17.1%)
-$33.83 M(+2697.8%)
Dec 2014
-$1.21 M(-96.3%)
-$12.59 M(+1.8%)
-$1.21 M(-178.1%)
Sep 2014
-
-$12.37 M(-310.2%)
$1.55 M(-54.3%)
Jun 2014
-
$5.88 M(-67.1%)
$3.39 M(-135.4%)
Mar 2014
-
$17.87 M(-281.7%)
-$9.58 M(-70.7%)
Dec 2013
-$32.66 M(-24.7%)
-$9.83 M(-6.6%)
-$32.66 M(-17.3%)
Sep 2013
-
-$10.53 M(+48.6%)
-$39.49 M(+8.2%)
Jun 2013
-
-$7.08 M(+35.9%)
-$36.51 M(-8.3%)
Mar 2013
-
-$5.21 M(-68.7%)
-$39.83 M(-8.2%)
Dec 2012
-$43.37 M(+113.7%)
-$16.66 M(+120.6%)
-$43.37 M(+62.4%)
Sep 2012
-
-$7.55 M(-27.4%)
-$26.71 M(+39.4%)
Jun 2012
-
-$10.40 M(+18.7%)
-$19.16 M(+118.7%)
Mar 2012
-
-$8.76 M
-$8.76 M
Dec 2011
-$20.29 M(+73.6%)
-
-
Dec 2010
-$11.69 M
-
-

FAQ

  • What is Prothena annual free cash flow?
  • What is the all time high annual FCF for Prothena?
  • What is Prothena annual FCF year-on-year change?
  • What is Prothena quarterly free cash flow?
  • What is the all time high quarterly FCF for Prothena?
  • What is Prothena quarterly FCF year-on-year change?
  • What is Prothena TTM free cash flow?
  • What is the all time high TTM FCF for Prothena?
  • What is Prothena TTM FCF year-on-year change?

What is Prothena annual free cash flow?

The current annual FCF of PRTA is -$136.72 M

What is the all time high annual FCF for Prothena?

Prothena all-time high annual free cash flow is $92.03 M

What is Prothena annual FCF year-on-year change?

Over the past year, PRTA annual free cash flow has changed by -$27.43 M (-25.10%)

What is Prothena quarterly free cash flow?

The current quarterly FCF of PRTA is -$45.20 M

What is the all time high quarterly FCF for Prothena?

Prothena all-time high quarterly free cash flow is $111.90 M

What is Prothena quarterly FCF year-on-year change?

Over the past year, PRTA quarterly free cash flow has changed by +$7.39 M (+14.06%)

What is Prothena TTM free cash flow?

The current TTM FCF of PRTA is -$155.12 M

What is the all time high TTM FCF for Prothena?

Prothena all-time high TTM free cash flow is $95.66 M

What is Prothena TTM FCF year-on-year change?

Over the past year, PRTA TTM free cash flow has changed by -$18.40 M (-13.46%)